<code id='DDC96E511E'></code><style id='DDC96E511E'></style>
    • <acronym id='DDC96E511E'></acronym>
      <center id='DDC96E511E'><center id='DDC96E511E'><tfoot id='DDC96E511E'></tfoot></center><abbr id='DDC96E511E'><dir id='DDC96E511E'><tfoot id='DDC96E511E'></tfoot><noframes id='DDC96E511E'>

    • <optgroup id='DDC96E511E'><strike id='DDC96E511E'><sup id='DDC96E511E'></sup></strike><code id='DDC96E511E'></code></optgroup>
        1. <b id='DDC96E511E'><label id='DDC96E511E'><select id='DDC96E511E'><dt id='DDC96E511E'><span id='DDC96E511E'></span></dt></select></label></b><u id='DDC96E511E'></u>
          <i id='DDC96E511E'><strike id='DDC96E511E'><tt id='DDC96E511E'><pre id='DDC96E511E'></pre></tt></strike></i>

          Home / comprehensive / knowledge

          knowledge


          knowledge

          author:fashion    Page View:84512
          Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

          In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

          The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks. 

          advertisement

          “Oh, crap,” Secrist said to herself.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In